Verenigde Staten - Engels - NLM (National Library of Medicine)

target corp. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.2 mg in 1 ml - anticavity aids in the prevention of dental cavities

Verenigde Staten - Engels - NLM (National Library of Medicine)

dentsply llc. professional division trading as "dentsply professional" - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 20 mg in 1 g - for topical application to aid in the protection against dental caries. the non-acidic fluoride is safe for patients with porcelain, composite restorations, and sealants. hypersensitivity to fluoride

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - sulfur hexafluoride - powder and solvent for dispersion for injection - 8microlitre/1ml

Israël - Engels - Ministry of Health

dexcel ltd, israel - sulphur hexafluoride - powder and solvent for dispersion for injection - sulphur hexafluoride 8 mcl/ml - sulfur hexafluoride - this medicinal product is for diagnostic use only. sonovue is for use with ultrasound imaging to enhance the echogenicity of the blood, which results in an improved signal to noise ratio. sonovue should only be used in patients where study without contrast enhancement is inconclusive.echocardiography: sonovue is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation.doppler of macrovasculature: sonovue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries by improving the doppler signal to noise ratio. sonovue increases the quality of the doppler flow image and the duration of clinically useful signal enhancement in portal vein assessment.doppler of microvasculature: sonovue improves display of the vascularity of liver and breast lesions during doppler sonography, leading to more specific lesion characterisation.

Ierland - Engels - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - ferric chloride hexahydrate; zinc chloride; manganese chloride tetrahydrate; copper chloride dihydrate; chromium trichloride hexahydrate; sodium selenite anhydrous; sodium molybdate dihydrate; sodium fluoride; potassium iodide - concentrate for solution for infusion - 10 millilitre(s) - electrolyte solutions; electrolytes in combination with other drugs

Ierland - Engels - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - zinc chloride ; cupric chloride dihydrate ; manganese chloride tetrahydrate ; sodium selenite pentahydrate ; sodium fluoride ; potassium iodide - solution for infusion - %v/v - electrolytes in combination with other drugs

Ierland - Engels - HPRA (Health Products Regulatory Authority)

b. braun medical limited - sodium chloride potassium chloride sodium lactate solution calcium chloride dihydrate - solution for infusion - 500ml,1000 %v/v

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - sodium fluoride 1.1mg equivalent to 0.5 mg elemental fluoride;   - tablet - 1.1 mg - active: sodium fluoride 1.1mg equivalent to 0.5 mg elemental fluoride   excipient: lactose monohydrate magnesium stearate maize starch - fluoride supplement

Verenigde Staten - Engels - NLM (National Library of Medicine)

the great atlantic + pacific tea company - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride .05 kg in 100 l - antiavity rinse aids in the prevention of dental cavities

Verenigde Staten - Engels - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.5 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 6 years of age when the fluoride content of drinking water is 0.3 ppm f* or to pediatric patients under age 3 years. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.